Stock Market & Financial News
Stryker Expands Foot & Ankle Innovation With Prophecy and smartHEX
SYK expands its Foot & Ankle portfolio with Prophecy for Incompass and smartHEX, linking planning, implants and limb reconstruction.
SYK +0.02% Can ADI's Industrial Segment Sustain Its Momentum Through 2026?
Analog Devices' Industrial segment surges 53% year over year in fiscal Q3 2026, but intense competition and inventory trends could shape its next phase.
ADI +1.38% MORPHO: As demand strengthens with $10.24B TVL, can price retest $3?
MORPHO defended $2 as Seed allocations, rising TVL, and bullish trader positioning strengthened underlying demand.
Experian Enhances Credit Underwriting With Early Affordability Checks
Experian has added a new feature to its Experian Marketplace that is designed to help lenders complete more verification and affordability checks earlier in the underwriting process for loans and credit cards, the company said in a Wednesday (Sept. 16) press release.
EXPGY +0.17% 
If AI Spending Keeps Exploding, Credo Stock Could Look Very Different by 2030
Credo Technology Group (NASDAQ:CRDO | CRDO Price Prediction) sits at the pinch point of the AI buildout. The fabless chip designer sells the copper cables, optical DSPs, retimers, and interconnect silicon that stitch hyperscaler GPU clusters together.
CRDO -9.51% 
“He's Back, He's Bigger Than Ever”: 24-Year-Old Who Blew Up $45 Billion Hedge Fund Is Back With Options Bet On AI Stocks
On September 11, 2026, Jim Cramer posted five words on X in reaction to CNBC's reporting that instantly ricocheted around finance Twitter: “HE's back, he's bigger than ever”.
NVDA -0.59% 
Zcash miner Fortitude taps former Hut 8 CEO to lead ahead of public listing
Former Hut 8 CEO Jaime Leverton will take the helm at Fortitude as the Zcash-focused miner expands its operations and moves toward a planned public listing.
Gang of 3: Zuckerberg, Musk, and Huang Call Trump to Oppose AI Regulation
Three of the loudest voices in AI spent last week working the phones.
META -0.96% 
Apple Is Quietly Building an AI Advantage Few Expected
When technology leaders scale their artificial intelligence platforms, they face a straightforward economic choice: rent computing capacity from third-party cloud providers, or build their own infrastructure. Apple Inc. NASDAQ: AAPL appears to have chosen the latter route.
AAPL -0.14% 
JEPQ vs. QQQI: Which Nasdaq-100 Covered-Call ETF Pays You More Safely?
JEPQ and QQQI both mail fat monthly checks from the Nasdaq-100, but their plumbing works so differently that the wrong account choice could quietly hand a chunk of your yield to the IRS.
JEPQ +0.02% 
FuelCell Jumps 13% as House Shifts Data Center Power Costs to Operators; Plug Power Climbs 7%, Bloom Energy Rises 3%
The U.S. House of Representatives has handed on-site power generators a policy win, and fuel cell stocks are responding in force Thursday morning.
BE -11.24% 
Securitize's Avalanche assets market cap surges 628% to $770M
Securitize's dominance on Avalanche highlights the growing influence of tokenization in blockchain finance, posing both opportunities and risks. Securitize's Avalanche assets market cap surges 628% to $770M.
Is SSR Mining Benefiting From Its 2025 Colorado Mine Acquisition?
SSRM's Cripple Creek and Victor acquisition is boosting gold production, but higher costs and capital spending shape the mine's 2026 outlook.
SSRM -2.81% 
Can JPM's Strong Q3 Capital Markets Outlook Help Sustain Fee Growth?
JPMorgan's third-quarter 2026 outlook signals mid-to-high teens growth in IB fees and Markets revenues, supporting fee growth.
JPM -1.47% 
IonQ Climbs 9% on Quantum Optimization Work With NVIDIA; D-Wave Rises 8%, Rigetti Gains 7%
Quantum computing stocks are trading like a thematic basket this morning, not like an industry being repriced.
IONQ +0.35% 
Everpure Stock Gains 34% in 6 Months: Here's What You Should Know
P is gaining market share as AI storage demand, hyperscaler wins and stronger FY27 guidance support its growth outlook.
P +1.76% 
RHHBY's Lunsumio Combo Meets Goal in 2L Follicular Lymphoma Study
Roche's Lunsumio-Revlimid combo meets its study goal in second-line or later follicular lymphoma, improving PFS versus rituximab plus Revlimid.
RHHBY +2.6% 
Can Starbucks' 600-650 New Stores Strengthen Its Global Growth?
SBUX plans 600-650 net new stores in fiscal 2026, leaning on international growth, licensing and disciplined development to expand globally.
SBUX -1.09% 
SCHW Client Assets Hit $13.41T in August: Will the Momentum Continue?
Schwab's record $64.8 billion in August core net new assets and $13.41 trillion in client assets highlight strong momentum across its platform.
SCHW -0.94% 
Roku's new Labs hub brings experimental apps to the big screen
Roku is turning your TV into its own testing grounds. On Thursday, the connected TV device maker unveiled the latest update to Roku OS, which introduces a new experience called Roku Labs that allows U.S. customers to access experimental apps made by the company.
ROKU -0.92% 
Ciena Corporation (CIEN) Discusses Financial Objectives, Margin Improvement and Demand Acceleration in Optical Systems Prepared Remarks Transcript
Ciena Corporation (CIEN) Discusses Financial Objectives, Margin Improvement and Demand Acceleration in Optical Systems Prepared Remarks Transcript
CIEN -0.74% 
Tempus AI Is Ripping 30% Higher This Week After Morgan Stanley Boosts Revenue Outlook
Tempus AI (NASDAQ:TEM | TEM Price Prediction) is having a breakout week after Morgan Stanley remarks on September 15 spotlighted fresh reimbursement-driven revenue lifts for the AI-powered diagnostics company. Shares have rallied 29.
MGHL 0% 
Cardano's Splash fix patches the exploit, but leaves 2.4M ADA missing and holders trapped
The exploit drained 2.42 million ADA net, while OADA lacks protocol redemption and faces a thin-pool overhang.
SpaceX: Volatility Is Here, But Hold On For The Long Haul
SpaceX is reaffirmed as a buy, with recent volatility presenting attractive entry points for long-term investors. Q2 revenue surged 92% y/y to $7.81 billion, far surpassing expectations and driven primarily by the Starlink connectivity segment. Starlink posted 66% y/y revenue growth and achieved its best quarter for net-new subscriber additions, highlighting accelerating traction.
SPCX +1.89% 
Will Higher Costs and Softer FICC Weigh on Goldman Q3 Momentum?
GS's softer Q3 FICC trends and rising expenses could temper the earnings benefit from its still-healthy IB pipeline.
GS -1.75% 
Is Docusign Stock Worth Buying as IAM Growth Meets Liquidity Risks?
Docusign's IAM mix, improving earnings outlook and discounted valuation support its growth case, while liquidity and pricing risks remain in focus.
DOCU +1.02% 
Valmont Industries Shares Rise 19% in 6 Months: Here's Why
VMI shares are gaining as utility demand, grid modernization, capacity expansion and productivity efforts lift growth and margins.
VMI -0.2% 
First American Raises Dividend by 11%, Boosts Shareholder Returns
FAF raises its quarterly dividend 11% to 61 cents, supported by strong liquidity, capital management and a solid dividend track record.
FAF -0.54% 
High Roller Stock Soars 200% YTD: Is There More Upside Ahead?
ROLR's 200% YTD surge comes as it nears a U.S. prediction-markets launch, adds marketing partners, and trades below its historical and industry P/B multiples.
ROLR +0.4% 
Progyny: Best-In-Class And Likely To Exceed Analyst Estimates In 2027
Progyny (PGNY) remains the US market leader in fertility benefits management, demonstrating robust growth, improving margins, and a compelling valuation despite recent volatility. PGNY's Q2 2026 results highlight 11% revenue growth ex-Amazon, margin expansion, and nearly 100% EPS growth guidance for 2026, supporting a continued buy rating. Secular tailwinds—rising infertility rates, delayed family formation, and underpenetrated employer markets—position PGNY for sustained double-digit growth and market share gains.
PGNY -0.52% 
